Jiarui Zheng, Xiaoxiao Wang, Zilong Wang, Linxiang Huang, Yandi Xie, Suzhen Jiang, Bo Feng. eALT-F: A New Non-Invasive Staging Method to Identify Medium to High-Risk Patients with HCC from Ultra-High HBV Viral Load Population — China, 2010–2023J. China CDC Weekly, 2023, 5(49): 1107-1114. DOI: 10.46234/ccdcw2023.207
|
Citation:
|
Jiarui Zheng, Xiaoxiao Wang, Zilong Wang, Linxiang Huang, Yandi Xie, Suzhen Jiang, Bo Feng. eALT-F: A New Non-Invasive Staging Method to Identify Medium to High-Risk Patients with HCC from Ultra-High HBV Viral Load Population — China, 2010–2023J. China CDC Weekly, 2023, 5(49): 1107-1114. DOI: 10.46234/ccdcw2023.207
|
Jiarui Zheng, Xiaoxiao Wang, Zilong Wang, Linxiang Huang, Yandi Xie, Suzhen Jiang, Bo Feng. eALT-F: A New Non-Invasive Staging Method to Identify Medium to High-Risk Patients with HCC from Ultra-High HBV Viral Load Population — China, 2010–2023J. China CDC Weekly, 2023, 5(49): 1107-1114. DOI: 10.46234/ccdcw2023.207
|
Citation:
|
Jiarui Zheng, Xiaoxiao Wang, Zilong Wang, Linxiang Huang, Yandi Xie, Suzhen Jiang, Bo Feng. eALT-F: A New Non-Invasive Staging Method to Identify Medium to High-Risk Patients with HCC from Ultra-High HBV Viral Load Population — China, 2010–2023J. China CDC Weekly, 2023, 5(49): 1107-1114. DOI: 10.46234/ccdcw2023.207
|